Clinical Trials Browser

Phase 2 × Muscle Invasive Bladder Cancer × RC48 antibody × Clear all

NCT05979740 2023-08-31

RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

Phase 2 Unknown

Muscle Invasive Bladder Cancer